vs
雅培（ABT）与Addus HomeCare Corp（ADUS）财务数据对比。点击上方公司名可切换其他公司
雅培的季度营收约是Addus HomeCare Corp的30.7倍（$11.5B vs $373.1M）。雅培净利率更高（15.5% vs 8.0%，领先7.5%）。Addus HomeCare Corp同比增速更快（25.6% vs 4.4%）。雅培自由现金流更多（$2.6B vs $16.1M）。过去两年Addus HomeCare Corp的营收复合增速更高（15.3% vs 7.2%）
雅培是总部位于美国伊利诺伊州雅培园的跨国医疗健康企业，业务覆盖美国境外市场药品销售、诊断产品、营养产品及医疗器械等板块，在全球医疗健康领域拥有较高的行业知名度与广泛的市场覆盖。
Addus HomeCare Corp是一家总部位于美国的家庭护理服务提供商，主要为老年人、残障人士及慢性病患者提供个人护理、居家健康支持、临终关怀等服务，业务覆盖美国多个州，合作方包括政府支付机构、私营保险公司及个人客户。
ABT vs ADUS — 直观对比
营收规模更大
ABT
是对方的30.7倍
$373.1M
营收增速更快
ADUS
高出21.1%
4.4%
净利率更高
ABT
高出7.5%
8.0%
自由现金流更多
ABT
多$2.6B
$16.1M
两年增速更快
ADUS
近两年复合增速
7.2%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $11.5B | $373.1M |
| 净利润 | $1.8B | $29.8M |
| 毛利率 | 57.0% | 33.1% |
| 营业利润率 | 19.6% | 11.3% |
| 净利率 | 15.5% | 8.0% |
| 营收同比 | 4.4% | 25.6% |
| 净利润同比 | -80.8% | 52.5% |
| 每股收益（稀释后） | $1.01 | $1.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABTADUS
| Q4 25 | $11.5B | $373.1M | ||
| Q3 25 | $11.4B | $362.3M | ||
| Q2 25 | $11.1B | $349.4M | ||
| Q1 25 | $10.4B | $337.7M | ||
| Q4 24 | $11.0B | $297.1M | ||
| Q3 24 | $10.6B | $289.8M | ||
| Q2 24 | $10.4B | $286.9M | ||
| Q1 24 | $10.0B | $280.7M |
净利润ABTADUS
| Q4 25 | $1.8B | $29.8M | ||
| Q3 25 | $1.6B | $22.8M | ||
| Q2 25 | $1.8B | $22.1M | ||
| Q1 25 | $1.3B | $21.2M | ||
| Q4 24 | $9.2B | $19.5M | ||
| Q3 24 | $1.6B | $20.2M | ||
| Q2 24 | $1.3B | $18.1M | ||
| Q1 24 | $1.2B | $15.8M |
毛利率ABTADUS
| Q4 25 | 57.0% | 33.1% | ||
| Q3 25 | 55.4% | 32.2% | ||
| Q2 25 | 56.4% | 32.6% | ||
| Q1 25 | 56.9% | 31.9% | ||
| Q4 24 | 55.0% | 34.2% | ||
| Q3 24 | 55.8% | 31.8% | ||
| Q2 24 | 55.6% | 32.5% | ||
| Q1 24 | 55.2% | 31.4% |
营业利润率ABTADUS
| Q4 25 | 19.6% | 11.3% | ||
| Q3 25 | 18.1% | 9.1% | ||
| Q2 25 | 18.4% | 9.4% | ||
| Q1 25 | 16.3% | 9.0% | ||
| Q4 24 | 17.4% | 9.1% | ||
| Q3 24 | 17.5% | 9.0% | ||
| Q2 24 | 16.1% | 9.1% | ||
| Q1 24 | 13.9% | 8.4% |
净利率ABTADUS
| Q4 25 | 15.5% | 8.0% | ||
| Q3 25 | 14.5% | 6.3% | ||
| Q2 25 | 16.0% | 6.3% | ||
| Q1 25 | 12.8% | 6.3% | ||
| Q4 24 | 84.1% | 6.6% | ||
| Q3 24 | 15.5% | 7.0% | ||
| Q2 24 | 12.5% | 6.3% | ||
| Q1 24 | 12.3% | 5.6% |
每股收益（稀释后）ABTADUS
| Q4 25 | $1.01 | $1.62 | ||
| Q3 25 | $0.94 | $1.24 | ||
| Q2 25 | $1.01 | $1.20 | ||
| Q1 25 | $0.76 | $1.16 | ||
| Q4 24 | $5.26 | $1.06 | ||
| Q3 24 | $0.94 | $1.10 | ||
| Q2 24 | $0.74 | $1.10 | ||
| Q1 24 | $0.70 | $0.97 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.9B | — |
| 总债务越低越好 | $12.9B | $121.0M |
| 股东权益账面价值 | $52.1B | $1.1B |
| 总资产 | $86.7B | $1.4B |
| 负债/权益比越低杠杆越低 | 0.25× | 0.11× |
8季度趋势，按日历期对齐
现金及短期投资ABTADUS
| Q4 25 | $8.9B | — | ||
| Q3 25 | $7.7B | — | ||
| Q2 25 | $7.3B | — | ||
| Q1 25 | $6.8B | $97.0M | ||
| Q4 24 | $8.0B | $98.9M | ||
| Q3 24 | $7.8B | $222.9M | ||
| Q2 24 | $7.2B | $173.3M | ||
| Q1 24 | $6.7B | $76.7M |
总债务ABTADUS
| Q4 25 | $12.9B | $121.0M | ||
| Q3 25 | — | $150.6M | ||
| Q2 25 | — | $169.1M | ||
| Q1 25 | — | — | ||
| Q4 24 | $14.1B | $218.4M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ABTADUS
| Q4 25 | $52.1B | $1.1B | ||
| Q3 25 | $51.0B | $1.0B | ||
| Q2 25 | $50.6B | $1.0B | ||
| Q1 25 | $48.8B | $995.4M | ||
| Q4 24 | $47.7B | $970.5M | ||
| Q3 24 | $39.8B | $947.6M | ||
| Q2 24 | $39.3B | $921.7M | ||
| Q1 24 | $38.8B | $725.1M |
总资产ABTADUS
| Q4 25 | $86.7B | $1.4B | ||
| Q3 25 | $84.2B | $1.4B | ||
| Q2 25 | $84.0B | $1.4B | ||
| Q1 25 | $81.4B | $1.4B | ||
| Q4 24 | $81.4B | $1.4B | ||
| Q3 24 | $74.4B | $1.2B | ||
| Q2 24 | $73.0B | $1.1B | ||
| Q1 24 | $72.5B | $1.0B |
负债/权益比ABTADUS
| Q4 25 | 0.25× | 0.11× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.17× | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.30× | 0.23× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.3B | $18.8M |
| 自由现金流经营现金流 - 资本支出 | $2.6B | $16.1M |
| 自由现金流率自由现金流/营收 | 22.9% | 4.3% |
| 资本支出强度资本支出/营收 | 6.0% | 0.7% |
| 现金转化率经营现金流/净利润 | 1.87× | 0.63× |
| 过去12个月自由现金流最近4个季度 | $7.4B | $103.8M |
8季度趋势，按日历期对齐
经营现金流ABTADUS
| Q4 25 | $3.3B | $18.8M | ||
| Q3 25 | $2.8B | $51.3M | ||
| Q2 25 | $2.0B | $22.5M | ||
| Q1 25 | $1.4B | $18.9M | ||
| Q4 24 | $2.9B | $10.4M | ||
| Q3 24 | $2.7B | $48.5M | ||
| Q2 24 | $2.0B | $18.8M | ||
| Q1 24 | $1.0B | $38.7M |
自由现金流ABTADUS
| Q4 25 | $2.6B | $16.1M | ||
| Q3 25 | $2.3B | $49.3M | ||
| Q2 25 | $1.5B | $21.3M | ||
| Q1 25 | $933.0M | $17.1M | ||
| Q4 24 | $2.1B | $8.7M | ||
| Q3 24 | $2.1B | $46.6M | ||
| Q2 24 | $1.4B | $17.7M | ||
| Q1 24 | $627.0M | $37.3M |
自由现金流率ABTADUS
| Q4 25 | 22.9% | 4.3% | ||
| Q3 25 | 20.2% | 13.6% | ||
| Q2 25 | 13.9% | 6.1% | ||
| Q1 25 | 9.0% | 5.1% | ||
| Q4 24 | 19.6% | 2.9% | ||
| Q3 24 | 20.2% | 16.1% | ||
| Q2 24 | 13.8% | 6.2% | ||
| Q1 24 | 6.3% | 13.3% |
资本支出强度ABTADUS
| Q4 25 | 6.0% | 0.7% | ||
| Q3 25 | 4.4% | 0.5% | ||
| Q2 25 | 4.5% | 0.4% | ||
| Q1 25 | 4.7% | 0.6% | ||
| Q4 24 | 6.6% | 0.6% | ||
| Q3 24 | 5.2% | 0.7% | ||
| Q2 24 | 5.1% | 0.4% | ||
| Q1 24 | 4.0% | 0.5% |
现金转化率ABTADUS
| Q4 25 | 1.87× | 0.63× | ||
| Q3 25 | 1.70× | 2.24× | ||
| Q2 25 | 1.15× | 1.02× | ||
| Q1 25 | 1.07× | 0.89× | ||
| Q4 24 | 0.31× | 0.53× | ||
| Q3 24 | 1.64× | 2.41× | ||
| Q2 24 | 1.51× | 1.04× | ||
| Q1 24 | 0.84× | 2.44× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ABT
暂无分部数据
ADUS
| Personal Care | $286.0M | 77% |
| Hospice | $70.0M | 19% |
| Home Health | $17.1M | 5% |
